These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


248 related items for PubMed ID: 3829466

  • 1. Research on dialyzers with improved biocompatibility.
    van der Steen A.
    Clin Nephrol; 1986; 26 Suppl 1():S39-42. PubMed ID: 3829466
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D.
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [Abstract] [Full Text] [Related]

  • 3. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
    Grooteman MP, Nubé MJ, van Limbeek J, van Houte AJ, Daha MR, van Geelen JA.
    ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
    [Abstract] [Full Text] [Related]

  • 4. A clinical study on different cellulosic dialysis membranes.
    Falkenhagen D, Bosch T, Brown GS, Schmidt B, Holtz M, Baurmeister U, Gurland H, Klinkmann H.
    Nephrol Dial Transplant; 1987; 2(6):537-45. PubMed ID: 3126455
    [Abstract] [Full Text] [Related]

  • 5. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
    de Vinuesa SG, Resano M, Luño J, Gonzalez C, Barril G, Junco E, Valderrabano F.
    Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
    [Abstract] [Full Text] [Related]

  • 6. Improvement of dialyzer compatibility by reduction of membrane surface area.
    Schaefer RM, Rautenberg W, Neumann S, Heidland A, Hörl WH.
    Clin Nephrol; 1986; 26 Suppl 1():S35-8. PubMed ID: 3644705
    [Abstract] [Full Text] [Related]

  • 7. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE, Johnson RJ, Simpson J, Chenoweth DE, Borgia J.
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [Abstract] [Full Text] [Related]

  • 8. Clinical sequelae of complement activation in hemodialysis.
    Hakim RM.
    Clin Nephrol; 1986 Feb; 26 Suppl 1():S9-12. PubMed ID: 3829474
    [Abstract] [Full Text] [Related]

  • 9. Dialyzer reuse--part II: advantages and disadvantages.
    Twardowski ZJ.
    Semin Dial; 2006 Feb; 19(3):217-26. PubMed ID: 16689973
    [Abstract] [Full Text] [Related]

  • 10. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE, Boberg U, Jacobson SH, Kjellstrand C, Ljungberg B, Skröder R.
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [Abstract] [Full Text] [Related]

  • 11. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination].
    Orłowski A, Szepietowski T.
    Polim Med; 1992 Nov; 22(1-2):59-72. PubMed ID: 1461837
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Reprocessing of capillary dialyzers].
    Stetsiuk EA, Iarmolinskiĭ IS, Ponomareva VIu, Makhlin NV.
    Urol Nefrol (Mosk); 1989 Nov; (1):55-9. PubMed ID: 2718285
    [Abstract] [Full Text] [Related]

  • 14. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K, Krouzzecký A, Polanská K, Mares J, Tomsů M, Bowry SK, Vienken J.
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [Abstract] [Full Text] [Related]

  • 15. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E, Moczulski D, Grzeszczak W, Gosek K, Augustyn M, Staszewicz P.
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [Abstract] [Full Text] [Related]

  • 16. [Interaction between blood and dialysis membrane].
    Szepietowski T, Orłowski A.
    Polim Med; 1991 Nov; 21(3-4):3-13. PubMed ID: 1822594
    [Abstract] [Full Text] [Related]

  • 17. Biocompatibility of hemodialysis using cuprophane membranes.
    Rommes JH, Sangster B, Borst C, Daha MR, van Heijst NP.
    Vet Hum Toxicol; 1987 Aug; 29(4):293-9. PubMed ID: 3629907
    [Abstract] [Full Text] [Related]

  • 18. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA, Woffindin C, Cox PJ, Goldfinch M, Roberts SJ.
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [Abstract] [Full Text] [Related]

  • 19. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
    Goldman M, Lietaer N, Lambert P, Thayse C, Vanherweghem JL.
    Life Support Syst; 1987 Oct; 5(4):317-22. PubMed ID: 3501504
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.